EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

sRAGE alleviates acute lung injury/acute respiratory distress syndrome (ALI/ARDS) by modulating HMGB1/RAGE pathway

Lu Liu, Yali Zhao, Dong Han, Shumei Yang, Guizuo Wang

International Immunopharmacology · 2026-12 · 191 · 117571

DOI: 10.1016/j.intimp.2026.117571 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026-12. Verfasst von Lu Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Shaanxi Provincial People's Hospital, No. 256, West Youyi Road, Xi'an, Shaanxi, 710068, PR Chin…. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-Mobility Group Box 1 (HMGB1) promotes acute lung injury/acute respiratory distress syndrome (ALI/ARDS), but the molecular mechanisms are not well understood. This study aimed to investigate the role of Receptor for Advanced-Glycation End products (RAGE) in HMGB1-regulated inflammatory response and lung injury in ALI/ARDS. The aim of the present study is to address this issue. LPS inhibited MLE-12 cells proliferation, induced cells apoptosis and ROS production via the HMGB1-RAGE axis, and this in turn activated MAPK and NF-κB signaling pathways. Pretreatment of cells with HMGB1 siRNA or sRAGE blocked LPS-induced alterations of MLE-12 cells proliferation, apoptosis, and ROS levels. Treatment with either FPS-ZM1 or sRAGE significantly repressed mice lung injury that was induced by LPS. HMGB1 and RAGE expression, p38 and p65 phosphorylation, as well as IL-6, TNF-α and IL-1β expression increased in ALI mice model, whereas all the factors were inhibited by FPS-ZM1 or sRAGE treatment. Taken together, our study indicates that LPS inhibited MLE-12 cells proliferation, induced cell apoptosis and ROS production by up-regulating HMGB1-RAGE axis, triggering the MAPK and NF-κB signaling pathway, and suggests that targeting this pathway might have potential value in the management of ALI.

Schlagwörter

Stichwörter der Autor:innen

ALI/ARDSHMGB1RAGEsRAGE

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Shaanxi Provincial People's Hospital, No. 256, West Youyi Road, Xi'an, Shaanxi, 710068, PR China.
  • Department of Respiratory and Critical Care Medicine, Shaanxi Provincial People's Hospital, No. 256, West Youyi Road, Xi'an, Shaanxi, 710068, PR China. Electronic address: zhxyxwgz@126.com.

Zitieren

APA

Liu, L., Zhao, Y., Han, D., Yang, S., & Wang, G. (2026). sRAGE alleviates acute lung injury/acute respiratory distress syndrome (ALI/ARDS) by modulating HMGB1/RAGE pathway. International Immunopharmacology, 191, 117571. https://doi.org/10.1016/j.intimp.2026.117571

Vancouver

Liu L, Zhao Y, Han D, Yang S, Wang G. sRAGE alleviates acute lung injury/acute respiratory distress syndrome (ALI/ARDS) by modulating HMGB1/RAGE pathway. International Immunopharmacology. 2026;191:117571. doi:10.1016/j.intimp.2026.117571

BibTeX
@article{Liu2026,
  author = {Liu, Lu and Zhao, Yali and Han, Dong and Yang, Shumei and Wang, Guizuo},
  title = {sRAGE alleviates acute lung injury/acute respiratory distress syndrome (ALI/ARDS) by modulating HMGB1/RAGE pathway},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {191},
  pages = {117571},
  doi = {10.1016/j.intimp.2026.117571}
}
Kostenlos starten →